drugset / Trial / NCT05449548
Lenalidomide in the Treatment of Mucosal Behçet's Syndrome
NaSingle-groupOpen-labelTreatment
Summary
The study is to evaluate the efficacy and safety of lenalidomide in the treatment of oral ulcers in adult patients with refractory mucosal Behcet's syndrome.
Timeline
- Start
- 2023-04-01
- Primary completion
- 2026-12-30
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenalidomide | Other / unclassified | 10 mg | — |